Work

Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility

Year: 2023

Type: article

Study design: Observational Study

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2023.03.012

Authors: Alicia K. Morgans, Matthew D. Galsky, Phoebe Wright, Zsolt Hepp, Nancy Chang, Candice L. Willmon, Steve Sesterhenn, Yutong Liu, Guru P. Sonpavde

Institutions: Dana-Farber Cancer Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Seagen (United States), Astellas Pharma (United States), University of Central Florida, AdventHealth

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma US, Seagen

OpenAlex ID: W4376868671

FWCI: 6.878

Cites: 19

Cited by: 30

Related to: 10